Advances in Protein Chemistry and Structural Biology

Author:   Rossen Donev (Head of Research, MicroPharm Limited, UK) ,  Rossen Delete Donev (Swansea University, UK) ,  Rossen Delete Donev (Swansea University, UK) ,  Rossen Delete Donev (Swansea University, UK)
Publisher:   Elsevier Science Publishing Co Inc
Volume:   101
ISBN:  

9780128033678


Pages:   424
Publication Date:   11 November 2015
Format:   Hardback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $451.44 Quantity:  
Add to Cart

Share |

Advances in Protein Chemistry and Structural Biology


Add your own review!

Overview

The Advances in Protein Chemistry and Structural Biology series is an essential resource for protein chemists. Each volume brings forth new information about protocols and analysis of proteins, with each thematically organized volume guest edited by leading experts in a broad range of protein-related topics.

Full Product Details

Author:   Rossen Donev (Head of Research, MicroPharm Limited, UK) ,  Rossen Delete Donev (Swansea University, UK) ,  Rossen Delete Donev (Swansea University, UK) ,  Rossen Delete Donev (Swansea University, UK)
Publisher:   Elsevier Science Publishing Co Inc
Imprint:   Academic Press Inc
Volume:   101
Dimensions:   Width: 15.20cm , Height: 2.50cm , Length: 22.90cm
Weight:   0.790kg
ISBN:  

9780128033678


ISBN 10:   0128033673
Pages:   424
Publication Date:   11 November 2015
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer Sara Karaki, Claudia Andrieu, Hajer Ziouziou and Palma Rocchi Anti-Tumor Lipids – Structure, Functions and Medical Applications Aneliya Kostadinova, Tanya Topouzova-Hristova, Albena Momchilova, Rumiana Tzoneva and Martin R. Berger Telomere Repeat Factor 2 (Trf2) is Responsible for the Telomere Attachment to the Nuclear Membrane Nadya V. Ilicheva, Olga I. Podgornaya and Alex P. Voronin Alterations in Gene Expression in Depression – Prospects for Personalize Patient Treatment Rossen Donev and Khaled Alawam Evolution and Coevolution of Prc2 Genes in Vertebrates and Mammals Xi Liu, Jingwen Yang, Nan Wu, Ruixian Song and Hao Zhu Quartz-Crystal Microbalance (QCM) for Public Health: An Overview of its Applications Nicola Luigi Bragazzi, Daniela Amicizia, Donatella Panatto, Daniela Tramalloni, Ivana Valle and Roberto Gasparini Porous Alumina as a Promising Biomaterial for Public Health Nicola Luigi Bragazzi, Roberto Gasparini, Daniela Amicizia, Donatella Panatto and Claudio Larosa Human Papillomavirus (HPV) Vaccine: State of the Art and Future Perspectives Donatella Panatto, Daniela Amicizia, Nicola Luigi Bragazzi, Emanuela Rizzitelli, Daniela Tramalloni, Ivana Valle and Roberto Gasparini SHOPIN: Semantic Homogeneity Optimization in Protein Interaction Networks Kire Trivodaliev, Slobodan Kalajdziski, Ilinka Ivanoska, Biljana Risteska Stojkoska and Ljupco Kocarev

Reviews

Author Information

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

wl

Shopping Cart
Your cart is empty
Shopping cart
Mailing List